Carbon monoxide: pro- or anti-angiogenic agent? Comment on Ahmad et al. (Thromb Haemost 2015; 113: 329–337)

Agnieszka Loboda; Alicja Jozkowicz; Jozef Dulak

doi:10.1160/TH15-01-0082

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2015; 114(02): 432-433
DOI: 10.1160/TH15-01-0082

Author Correspondence

Schattauer GmbH

Carbon monoxide: pro- or anti-angiogenic agent? Comment on Ahmad et al. (Thromb Haemost 2015; 113: 329–337)

Authors

Agnieszka Loboda

¹Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland

²Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland
Alicja Jozkowicz

¹Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
Jozef Dulak

¹Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland

Abstract

Full Text

References

References
1 Motterlini R. et al. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 2002; 90: E17-24.
2 Ahmad S. et al. Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. Thromb Hae-most 2015; 113: 329-337.
3 Deshane J. et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 2007; 204: 605-618.
4 Dulak J. et al. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 2002; 4: 229-240.
5 Jozkowicz A. et al. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 2003; 05: 155-162.
6 Vitek L. et al. Antiproliferative effects of carbon monoxide on pancreatic cancer. Dig Liver Dis 2014; 46: 369-375.
7 Motterlini R. et al. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 2005; 19: 284-286.
8 Wegiel B. et al. Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation 2010; 121: 537-548.
9 Otterbein LE. et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 09: 183-190.
10 Schwer CI. et al. Carbon monoxide releasing molecule-2 inhibits pancreatic stellate cell proliferation by activating p38 mitogen-activated protein kinase/heme oxygenase-1 signaling. Mol Pharmacol 2010; 77: 660-669.
11 Song R. et al. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 2004; 172: 1220-1226.
12 Skrzypek K. et al. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid Redox Signal 2013; 19: 644-660.
13 Was H. et al. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 2006; 169: 2181-2198.
14 Reiter CE, Alayash AI. Effects of carbon monoxide (CO) delivery by a CO donor or hemoglobin on vascular hypoxia inducible factor 1alpha and mitochondrial respiration. FEBS Open Bio 2012; 02: 113-118.
15 Choi YK. et al. Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein. J Biol Chem 2010; 285: 32116-32125.
16 Wegiel B. et al. The social network of carbon mon-oxide in medicine. Trends Mol Med 2013; 19: 3-11.
17 Li Volti G. et al. Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells. Antioxid Redox Signal 2005; 07: 704-710.
18 Ahanger AA. et al. Wound healing activity of carbon monoxide liberated from CO-releasing molecule (CO-RM). Naunyn Schmiedebergs Arch Pharmacol 2011; 384: 93-102.